Skip to main content
QBTS logo

QBTS · D-Wave Quantum Inc. · Documents

Track QBTS — free
$9.05 -1.33 (-12.81%) At close · Nov 5 Play latest call Q2 2026 earnings call transcript
Market Cap
$3.28B
Shares
369.26M
Volume · Nov 5 25.33M Avg daily vol (3M) 15.21M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $24.59M up 178.5% 10-K filed Feb 26, 2026 Quarterly report FY2026 Q2 Revenue $3.08M down 0.6% 10-Q filed Aug 6, 2026 Latest results Financial results 8-K filed Aug 6, 2026 Earnings call Q2 2026 earnings call Held Aug 6, 2026
2026
Oct 28
Current report 8-K
Quantum optimization collaboration targets production deployments

D-Wave Quantum Inc. and LG CNS Co., Ltd. signed a non-binding MOU to advance enterprise quantum optimization in South Korea and international markets. Shionogi & Co., Ltd. won first place in NEDO’s Quality of Life category, receiving a ¥40 million prize.

Regulation FD disclosure
3 source passages
D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, and LG CNS Co., Ltd. (“LG CNS”), a leading AI transformation company in South Korea, today announced that the companies have signed a non-binding memorandum of understanding (“MOU”) to advance the adoption of quantum computing for enterprise optimization in South Korea and international markets. D-Wave Quantum Inc. (Nasdaq: QBTS) ("D-Wave"), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, today announced that its customer Shionogi & Co., Ltd. (“Shionogi”) has won first place in the Quality of Life (QOL) category of the NEDO Challenge for its research exploring the application of quantum computing to drug discovery. The ¥40 million NEDO prize will support Shionogi’s continued research into applying quantum computing to one of the pharmaceutical industry’s most complex challenges: designing promising new drug candidate molecules. Open the document at this passage
Oct 1
Current report 8-K
Regulation FD disclosure

D-Wave Quantum Inc. launched its gate-model quantum computing simulator beta program on Oct. 1, 2026, giving select customers early access for error-aware programming before general availability.

Sep 22
Current report 8-K/A Events of Aug 19
Director or officer change, or executive pay

D-Wave Quantum Inc. appointed Greg Golkov Acting Chief Financial Officer effective September 2, 2026, with a $5,500.00 monthly allowance, a $550,000.00 restricted stock unit grant and a potential $67,000.00 completion bonus.

Sep 21
Current report 8-K Events of Sep 18
Director or officer change, or executive pay

D-Wave Quantum Inc. appointed Bernard Gavgani as an independent Class II director effective September 18, 2026, and he will serve on the Cybersecurity Committee under the compensation terms for non-employee directors.

Sep 10
Current report 8-K
Other events AI summary on its way
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $3.08M ▼ 0.6% Net loss $48.03M Diluted EPS -$0.13
May 21
Current report 8-K
Other events AI summary on its way
May 13
Current report 8-K Events of May 12
Other events AI summary on its way
May 12
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $2.86M ▼ 80.9% Net loss $18.36M Diluted EPS -$0.05
Apr 23
Proxy statement DEF 14A Meeting Jun 4, 2026
Proxy statement AI summary on its way
Feb 26
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $24.59M ▲ 178.5% Net loss $355.06M Diluted EPS -$1.11
Jan 20
Current report 8-K
Other events AI summary on its way
Showing 1–50 of 250 documents
Key facts CIK 1907982 CUSIP 26740W109 13F (30d) 256 filings 234 filers Visit website Investor relations